Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yogesh M Shastri

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
World Journal of Gastroenterology|July 16, 2014
Gastroenteric tube feeding: techniques, problems and solutionsIrina Blumenstein, Yogesh M Shastri, Jürgen Stein
Scandinavian Journal of Gastroenterology|September 14, 2007
Autologous blood as a submucosal fluid cushion for endoscopic mucosal therapies: results of an ex vivo studyYogesh M Shastri, Susanne Kriener, Wolfgang F Caspary, et al.
Gastrointestinal Endoscopy|April 1, 2008
New introducer PEG gastropexy does not require prophylactic antibiotics: multicenter prospective randomized double-blind placebo-controlled studyYogesh M Shastri, Nicolas Hoepffner, Angelika Tessmer, et al.
Carcinogenesis|June 12, 2008
PPARgamma is involved in mesalazine-mediated induction of apoptosis and inhibition of cell growth in colon cancer cellsMarkus Schwab, Veerle Reynders, Stefan Loitsch, et al.
The American Journal of Medicine|November 26, 2008
Prospective multicenter study evaluating fecal calprotectin in adult acute bacterial diarrheaYogesh M Shastri, Dominik Bergis, Nada Povse, et al.
World Journal of Gastroenterology|June 15, 2007
Liver biochemistry profile, significance and endoscopic management of biliary tract complications post orthotopic liver transplantationYogesh M Shastri, Nicolas M Hoepffner, Bora Akoglu, et al.
The American Journal of Gastroenterology|May 31, 2008
Comparison of an established simple office-based immunological FOBT with fecal tumor pyruvate kinase type M2 (M2-PK) for colorectal cancer screening: prospective multicenter studyYogesh M Shastri, Stefan Loitsch, Nicolas Hoepffner, et al.
International Journal of Cancer|August 25, 2006
Prospective multicenter evaluation of fecal tumor pyruvate kinase type M2 (M2-PK) as a screening biomarker for colorectal neoplasiaYogesh M Shastri, Marc Naumann, Gerhard M Oremek, et al.
Diagnostics (Basel, Switzerland)|September 28, 2021
EUS-Guided Biopsy with a Novel Puncture Biopsy Forceps Needle-Feasibility StudyGeke Litjens, Christian Gerges, Yogesh M Shastri, et al.
Journal of Gastroenterology and Hepatology|February 18, 2022
Emerging inflammatory bowel disease demographics, phenotype, and treatment in South Asia, South-East Asia, and Middle East: Preliminary findings from the Inflammatory Bowel Disease-Emerging Nations' ConsortiumRupa Banerjee, Partha Pal, Ida Hilmi, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
World Journal of Gastroenterology|July 16, 2014
Gastroenteric tube feeding: techniques, problems and solutionsIrina Blumenstein, Yogesh M Shastri, Jürgen Stein
Scandinavian Journal of Gastroenterology|September 14, 2007
Autologous blood as a submucosal fluid cushion for endoscopic mucosal therapies: results of an ex vivo studyYogesh M Shastri, Susanne Kriener, Wolfgang F Caspary, et al.
Gastrointestinal Endoscopy|April 1, 2008
New introducer PEG gastropexy does not require prophylactic antibiotics: multicenter prospective randomized double-blind placebo-controlled studyYogesh M Shastri, Nicolas Hoepffner, Angelika Tessmer, et al.
Carcinogenesis|June 12, 2008
PPARgamma is involved in mesalazine-mediated induction of apoptosis and inhibition of cell growth in colon cancer cellsMarkus Schwab, Veerle Reynders, Stefan Loitsch, et al.
The American Journal of Medicine|November 26, 2008
Prospective multicenter study evaluating fecal calprotectin in adult acute bacterial diarrheaYogesh M Shastri, Dominik Bergis, Nada Povse, et al.
World Journal of Gastroenterology|June 15, 2007
Liver biochemistry profile, significance and endoscopic management of biliary tract complications post orthotopic liver transplantationYogesh M Shastri, Nicolas M Hoepffner, Bora Akoglu, et al.
The American Journal of Gastroenterology|May 31, 2008
Comparison of an established simple office-based immunological FOBT with fecal tumor pyruvate kinase type M2 (M2-PK) for colorectal cancer screening: prospective multicenter studyYogesh M Shastri, Stefan Loitsch, Nicolas Hoepffner, et al.
International Journal of Cancer|August 25, 2006
Prospective multicenter evaluation of fecal tumor pyruvate kinase type M2 (M2-PK) as a screening biomarker for colorectal neoplasiaYogesh M Shastri, Marc Naumann, Gerhard M Oremek, et al.
Diagnostics (Basel, Switzerland)|September 28, 2021
EUS-Guided Biopsy with a Novel Puncture Biopsy Forceps Needle-Feasibility StudyGeke Litjens, Christian Gerges, Yogesh M Shastri, et al.
Journal of Gastroenterology and Hepatology|February 18, 2022
Emerging inflammatory bowel disease demographics, phenotype, and treatment in South Asia, South-East Asia, and Middle East: Preliminary findings from the Inflammatory Bowel Disease-Emerging Nations' ConsortiumRupa Banerjee, Partha Pal, Ida Hilmi, et al.
Pageof 1